Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Hoffmann

Showing results (1-10 of 312) with videos related to

Pageof 32
Sort By:
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|December 9, 2024
[Long-term results of the ORATOR-study: radiotherapy versus transoral robotic surgery for oropharyngeal cancer]Alexander Fabian, Markus Hoffmann
Psychiatrische Praxis|November 16, 2006
[Frequency and costs of additional hospitalisations in the year after inpatient or day hospital detoxification treatment]Gerd Weithmann, Markus Hoffmann
Cell Research|December 14, 2021
Novel SARS-CoV-2 receptors: ASGR1 and KREMEN1Markus Hoffmann, Stefan Pöhlmann
Translational Oncology|June 9, 2019
HPV and Oropharyngeal Cancer in the Eighth Edition of the TNM Classification: Pitfalls in PracticeMarkus Hoffmann, Silke Tribius
Scientific Reports|February 20, 2025
Spotlight on amino acid changing mutations in the JAK-STAT pathway: from disease-specific mutation to general mutation databasesMarkus Hoffmann, Lothar Hennighausen
Deutsches Arzteblatt International|April 5, 2013
Human papilloma virus infection in head and neck cancerSilke Tribius, Markus Hoffmann
Laryngo- Rhino- Otologie|January 24, 2018
[HPV and oropharyngeal squamous cell cancer in the 8th edition of the TNM classification]Markus Hoffmann, Silke Tribius
European Addiction Research|August 20, 2005
A randomised clinical trial of in-patient versus combined day hospital treatment of alcoholism: primary and secondary outcome measuresGerd Weithmann, Markus Hoffmann
Cell Host & Microbe|June 15, 2018
Cell Entry of Influenza A Viruses: Sweet Talk between HA and Ca<sub>V</sub>1.2Markus Hoffmann, Stefan Pöhlmann
Nature Microbiology|July 1, 2021
How SARS-CoV-2 makes the cutMarkus Hoffmann, Stefan Pöhlmann
Pageof 32

Showing results (1-10 of 312) with videos related to

Sort By:
Pageof 32
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|December 9, 2024
[Long-term results of the ORATOR-study: radiotherapy versus transoral robotic surgery for oropharyngeal cancer]Alexander Fabian, Markus Hoffmann
Psychiatrische Praxis|November 16, 2006
[Frequency and costs of additional hospitalisations in the year after inpatient or day hospital detoxification treatment]Gerd Weithmann, Markus Hoffmann
Cell Research|December 14, 2021
Novel SARS-CoV-2 receptors: ASGR1 and KREMEN1Markus Hoffmann, Stefan Pöhlmann
Translational Oncology|June 9, 2019
HPV and Oropharyngeal Cancer in the Eighth Edition of the TNM Classification: Pitfalls in PracticeMarkus Hoffmann, Silke Tribius
Scientific Reports|February 20, 2025
Spotlight on amino acid changing mutations in the JAK-STAT pathway: from disease-specific mutation to general mutation databasesMarkus Hoffmann, Lothar Hennighausen
Deutsches Arzteblatt International|April 5, 2013
Human papilloma virus infection in head and neck cancerSilke Tribius, Markus Hoffmann
Laryngo- Rhino- Otologie|January 24, 2018
[HPV and oropharyngeal squamous cell cancer in the 8th edition of the TNM classification]Markus Hoffmann, Silke Tribius
European Addiction Research|August 20, 2005
A randomised clinical trial of in-patient versus combined day hospital treatment of alcoholism: primary and secondary outcome measuresGerd Weithmann, Markus Hoffmann
Cell Host & Microbe|June 15, 2018
Cell Entry of Influenza A Viruses: Sweet Talk between HA and Ca<sub>V</sub>1.2Markus Hoffmann, Stefan Pöhlmann
Nature Microbiology|July 1, 2021
How SARS-CoV-2 makes the cutMarkus Hoffmann, Stefan Pöhlmann
Pageof 32